Meta-analysis of efficacy and safety of apixaban and uninterrupted apixaban therapy compared to vitamin K antagonists in patients undergoing catheter ablation for atrial fibrillation.
作者:
主题词
老年人(Aged);心房颤动(Atrial Fibrillation);导管消融术(Catheter Ablation);因果律(Causality);共病现象(Comorbidity);剂量效应关系, 药物(Dose-Response Relationship, Drug);女(雌)性(Female);纤维蛋白溶解药(Fibrinolytic Agents);出血(Hemorrhage);人类(Humans);男(雄)性(Male);中年人(Middle Aged);手术后并发症(Postoperative Complications);患病率(Prevalence);吡唑类(Pyrazoles);吡啶酮类(Pyridones);危险因素(Risk Factors);血栓栓塞(Thromboembolism);治疗结果(Treatment Outcome);维生素K(Vitamin K)
DOI
10.1007/s10840-016-0195-5
PMID
27771820
发布时间
2018-11-13
- 浏览50
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文